Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection
Clinical trial NCT02340962 · COMPLETED
Trial details
- NCT number
- NCT02340962
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-08-12
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.